Comment: Kidney surgery may be unneeded in many intermediate-risk patients

Genetic testing of early breast tumours could allow patients to go without chemo

Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy

Kidney surgery may be unneeded in many intermediate-risk patients

A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers

What will we expect from novel therapies for oesophageal and gastric malignancies?

Immunotherapy trials and hyperprogressive disease

The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients

Development of blood tests for early lung cancer

Matching personalised therapies to patients in the IMPACT trial

Development of blood tests for early lung cancer

Editor’s Choice for May 2018